'Dagger' cells: this is the new and improved immunotherapy'made in Spain' against cancer. Luis Álvarez Vallina, 'father' of this treatment, explains it.
In experimental models this new immunotherapy is more effective than CAR-T against multiple myeloma. Two years for human trials for STAb-T cells, which are produced in a similar way and recognize the same antigen, called BCMA, which is only present in tumor cells. The team in Spain wants to start human trials as soon as possible.